Press Releases

Former Soniwala Hematology Oncology Associates caps year of growth with a Grand Re-Opening event, new name
Wednesday, July 19, 2017

An established hematology-oncology practice in the Buffalo Northtowns has capped a year of growth with an expansion and rebrand. Soniwala Hematology Oncology Associates, which has been part of the Roswell Park Cancer Institute community cancer practice network since 2014, is now Roswell Park Hematology Oncology Northtowns

Tuesday, July 18, 2017

BUFFALO, N.Y. — A group of retired firefighters dedicated to raising funds for cancer research visited Roswell Park Cancer Institute today to make a significant donation that will go toward lung and prostate cancer research.

Emerging Scholars Award recognizes Danielle Twum for scientific achievement, professional development
Monday, July 17, 2017
Danielle Twum at the NCI’s Cure Awards Program in June.

BUFFALO, N.Y.

Friday, July 14, 2017

Sai Yendamuri, MD, FACS, Chair of the Department of Thoracic Surgery at Roswell Park Cancer Institute, received a prestigious award at a recent international gathering of thoracic surgeons.

Tuesday, June 27, 2017

Khurshid Guru, MD, one of the most experienced and accomplished robotic surgeons in the world, has been named Chair of the Department of Urology at Roswell Park Cancer Institute. James Mohler, MD, has assumed the new role of Chief of Inter-Institutional Academics and will act as Roswell Park’s point person and liaison for translational research collaborations between Roswell Park and the University at Buffalo.

Saturday, June 24, 2017

The Ride For Roswell, New York State’s largest single-day cycling fundraiser, concluded its 22nd year this weekend by raising a total of $4.6 million for cancer research and patient-care programs at Roswell Park Cancer Institute (RPCI).

Monday, June 19, 2017

A new study from Roswell Park Cancer Institute reporting the findings of the first clinical trial to evaluate the immune effects of high-dose radiation therapy followed by surgery in patients with advanced kidney cancer may also set the stage for combination treatments with immunotherapy.

Thursday, June 8, 2017

BUFFALO, N.Y. — Roswell Park Cancer Institute’s engagement with elected officials and government agencies will be led by Laura Krolczyk, who has been promoted to Vice President of External Affairs, and Leah Halton-Pope, who joins the Institute as Director of Government and Community Relations.

Thursday, June 8, 2017

Ryan Grady, CPA, has been appointed Vice President of Finance and Payer Relations at Roswell Park Cancer Institute and will lead the Institute’s finance team. He will oversee Roswell Park’s financial reporting, accounting and treasury management operations, financial planning and reimbursement operations.

Friday, June 2, 2017

BUFFALO, N.Y. — The class of immunotherapies known as checkpoint inhibitors have proven to be a highly effective and advantageous treatment option for many cancer patients, but they don’t work well for everyone, and oncologists have no reliable way to determine in advance which patients are likely to respond to these drugs. 

Friday, June 2, 2017

An international team of researchers has performed a follow-up analysis based on a large clinical study of a maintenance therapy for patients with multiple myeloma. Philip McCarthy, MD, of Roswell Park Cancer Institute was principal investigator of a phase III study that showed that treatment with lenalidomide following autologous hematopoietic stem cell transplant improved both progression-free survival and overall survival for newly diagnosed multiple myeloma patients.

Thursday, June 1, 2017

New research to be presented at the American Society of Clinical Oncology (ASCO) 53rd Annual Meeting in Chicago shows that a previously untested combination of a monoclonal antibody-drug conjugate with a common chemotherapy agent has a high complete-response rate in children and young adults with relapsed or refractory Hodgkin lymphoma. This cooperative-group clinical trial, Children’s Oncology Group study AHOD1221 (NCT01780662), was led by Kara Kelly, MD, Waldemar J. Kaminski Endowed Chair of Pediatrics at Roswell Park Cancer Institute.